Response to the Comment on "Somatostatin as Inflow Modulator in Liver-transplant Recipients With Severe Portal Hypertension: A Randomized Trial"

Ann Surg. 2021 Aug 1;274(2):e195-e196. doi: 10.1097/SLA.0000000000003676.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Hypertension, Portal*
  • Portal Pressure
  • Somatostatin*
  • Transplant Recipients

Substances

  • Somatostatin